- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03222193
Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring (SCORED)
May 9, 2018 updated by: Tongue Laboratory
The Tongue Right Positioner (TRP Snorless™) is a medical device designed to restore physiological tongue positions when functioning or at rest and increase tongue muscles tone.
Patient wears TRP Snorless™ daily at least 5 hours during night.
Published data suggested that TRP Snorless™ increases oropharynx diameter and nasal patency, favouring airflow in upper airways.
Independently of patient's adherence to daily myofascial exercises, the TRP Snorless™ treatment should increase tongue muscles' tone and decrease the risk of snoring during sleep.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Praha 4, Czechia, 149 00
- Recruiting
- Poliklinika Šustova 1930/2
-
Contact:
- Filip Bochníček, MuDr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Man or woman ≥ 18 years and ≤ 65 years at the time of signing informed consent
- Listed as continuous snorer (snoring at least 4 nights/week)
- Answer "Extremely loud" or "very loud" to question 1 of SBPS at screening
- Answer "very severe" or "severe" to question 2 of SBPS at screening
- Answer "extremely" or "quite a bit" to question 3 of SBPS at screening
- Dated and signed informed consent
- BMI ≤ 35
Exclusion Criteria:
- Severe Mandibular retrognathia and micrognathia
- Narrow and deep palate (less than 3 cm wide)
- Lack of three consecutive teeth in the area of (15-16-17-18) or (25-26-27-28).
- Lingual or labial short frenulum (the tongue cannot reach the upper incisors when mouth can be opened for two fingers)
- Intolerable gag reflex
- Known nasal septal deviation
- Neck circumference > 46 cm
- Patient currently treated for OSA
- Patient with AHI≥30 events/hour or with AHI>15 and (SFI) Sleep Fragmentation Index > 20
- Patient currently treated for central sleep apnoea
- Addiction to alcoholic beverages (5 drinks per day per NIAAA)
- Under constant pharmacological treatment for depression, anxiety, chronic pain, insomnia
- Hypertrophy of tonsils
- Macroglossia
- Hypertrophy of uvula
- Primary gastroesophageal reflux
- Any other pathology preventing subject from complying with the protocol
- Subject with recent oropharyngeal surgery or likely during the study
- Mental inability, unwillingness or language barrier precluding adequate understanding of or compliance with study procedures
- Pregnancy
- Patient with severe Chronic Obstructive Pulmonary Disease
- Asthmatic patient under inhaled corticoid therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TRP group
Snoring subjects treated with the Tongue Right Positioner (TRP) medical device
|
3 months of TRP tongue retraining
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Snore Index
Time Frame: 3 months
|
number of snores >36 dB per hour of sleep by BresoDx
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean sound of snoring/night
Time Frame: 3 months
|
(dB), in supine, non-supine and both positions by BresoDx
|
3 months
|
|
Maximum sound of snoring/night
Time Frame: 3 months
|
(dB), in supine, non-supine and both positions by BresoDx
|
3 months
|
|
Sleep time
Time Frame: 3 months
|
Total sleep time (h), in supine, non-supine and both positions by BresoDx
|
3 months
|
|
Apnoea Hypopnea Index
Time Frame: 3 months
|
(AHI) Number of apnea/hypopnea per hour of sleep, in supine, non-supine and both positions by BresoDx
|
3 months
|
|
Orofacial functional score (NOT-S questionnaire)
Time Frame: 3 months
|
Using NOT-S questionnaire
|
3 months
|
|
Tongue Endurance score
Time Frame: 3 months
|
Using IOPI medical device
|
3 months
|
|
Quality of sleep
Time Frame: 3 months
|
Using Spiegel questionnaire
|
3 months
|
|
Comfort / Safety
Time Frame: 3 months
|
Using homemade questionnaire relative to TRP snorless TM
|
3 months
|
|
Nasal patency
Time Frame: 3 months
|
Measure of the Peak Nasal Inspiratory Flow by In-check PNIF meter
|
3 months
|
|
Treatment compliance
Time Frame: 3 months
|
Using the The TheraMon® temperature micro sensor
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 16, 2017
Primary Completion (Anticipated)
December 15, 2018
Study Completion (Anticipated)
June 15, 2019
Study Registration Dates
First Submitted
July 17, 2017
First Submitted That Met QC Criteria
July 17, 2017
First Posted (Actual)
July 19, 2017
Study Record Updates
Last Update Posted (Actual)
May 11, 2018
Last Update Submitted That Met QC Criteria
May 9, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRP-S-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Snoring
-
Merz Pharmaceuticals GmbHTerminatedHabitual SnoringGermany
-
Johns Hopkins UniversityWithdrawn
-
Philips RespironicsCompleted
-
Sommetrics, Inc.Withdrawn
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted
-
University of HelsinkiHelsinki University Central Hospital; Olympus Surgical Technologies Europe,...Completed
Clinical Trials on TRP
-
César Fernández-de-las-PeñasUniversity of AlcalaCompleted
-
Indiana UniversityRecruitingPancreatitis | PancreatectomyUnited States
-
Beijing HospitalBeijing Municipal Health CommissionRecruitingPrimary Dysmenorrhea | Acupuncture | Trigger Point Pain, MyofascialChina
-
Universidad Rey Juan CarlosHospital General Universitario Gregorio MarañonCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedVisual PerformanceUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Maastricht University Medical CenterNetherlands Brain FoundationTerminated
-
Pomeranian Medical University SzczecinMinistry of Health, PolandCompleted
-
Medical University of ViennaCompletedST-Elevation Myocardial InfarctionAustria
-
AmgenRecruitingProstate CancerUnited States, Germany